SGRY
$12.65
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.
Recent News
Surgery Partners (SGRY) Is Down 9.7% After Soft 2026 Outlook And New Buyback Plan - Has The Bull Case Changed?
Surgery Partners recently reported fourth-quarter and full-year 2025 results showing higher sales but continued net losses, issued softer 2026 revenue guidance of US$3.35 billion to US$3.45 billion, launched a new US$200 million share repurchase authorization, and continued expanding its outpatient footprint with the acquisition of Preferred Vascular Group. These updates, combined with insider share sales to cover tax obligations and an activist investor push for board and portfolio changes,...
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Ortelius Targets Surgery Partners Governance While Shares Screen As Undervalued
Ortelius Advisors has issued an open letter to Surgery Partners (NasdaqGS:SGRY) calling for major changes to the board and management team. The activist investor cites destruction of stockholder value and urges a reassessment of the company’s direction. The campaign brings public pressure on Surgery Partners’ leadership and puts potential corporate governance changes on the table. Surgery Partners operates a network of surgical facilities, positioning it within the outpatient and ambulatory...
Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY)
Let’s dig into the relative performance of Surgery Partners (NASDAQ:SGRY) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
3 Russell 2000 Stocks with Questionable Fundamentals
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.